Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)
NCT00719680
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Immune Deficiency
Interventions
BIOLOGICAL:
IgPro20
Sponsor
CSL Behring